SMTL ID : 5nvw.1 (3 other biounits)

pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(cyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 6)

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.20 Å
Oligo State
hetero-1-1-1-mer
Ligands
1 x 9BW: (2~{S},4~{R})-1-[(2~{S})-2-(cyclopropylcarbonylamino)-3,3-dimethyl-butanoyl]-~{N}-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Soares, P. et al., Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298). J. Med. Chem. (2018)
Release Date
2017-09-20
Peptides
Elongin-B: A
Elongin-C: B
Von Hippel-Lindau disease tumor suppressor: C
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B
C
C

Elongin-B

Elongin-C

Von Hippel-Lindau disease tumor suppressor

Related Entries With Identical Sequence

1lqb.1 | 1lqb.2 | 2c9w.1 | 2izv.1 | 3dcg.1 | 3dcg.2 | 3zng.1 | 3zng.2 | 3zrc.1 | 3zrc.2 | 3zrc.3 | 3zrc.4 | 3zrf.1 | 3zrf.2 | 3zrf.3 | 3zrf.4 | 3ztc.1 | 3ztc.2 | 3ztc.3 | 3ztc.4 | 3ztd.1 | 3ztd.2 | 3ztd.3 | 3ztd.4 | 3zun.1 | 3zun.2 | 3zun.3 | 3zun.4 | 4ajy.1 | 4awj.1  more...